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Abstract 
The diverse, specialized genes in today’s lifeforms evolved from a common core of ancient, elementary 
genes. However, these genes did not evolve individually: gene expression is controlled by a complex 
network of interactions, and alterations in one gene may drive reciprocal changes in its proteins’ binding 
partners. We show that the topology of a leukemia gene regulatory network is strongly coupled with 
evolutionary properties. Slowly-evolving (“cold”), old genes tend to interact with each other, as do 
rapidly-evolving (“hot”), young genes, causing genes to evolve in clusters. We argue that gene 
duplication placed old, cold genes at the center of the network, and young, hot genes on the periphery, 
and demonstrate this with single-node centrality measures and two new measures of efficiency. 
Integrating centrality measures with evolutionary information, we define a medically-relevant “cancer 
network core,” strongly enriched for common cancer mutations (𝑝 = 2 × 10−14). This could aid in 
identifying driver mutations and therapeutic targets. 
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Significance 
We found strong relationships between the topological and evolutionary properties of an acute myeloid 
leukemia (AML) gene regulatory network (GRN). Interacting genes tend to have similar evolutionary 
ages and rates, causing the GRN to segregate into slowly-evolving (“cold”), old gene communities and 
rapidly-evolving (“hot”), young gene communities. The coldest, oldest communities are centrally-located 
and enriched for fundamental functional groups, whereas the hottest, youngest communities are 
peripheral and enriched for tissue-specific functions. We also found that driver mutations for AML in 
particular, and for cancer in general, tend to be in the cold, central “cancer core.” The identification of 
this core could aid in targeted therapies for AML. 
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Introduction 
The evolutionary history of a gene can be mapped in various ways. The absolute evolutionary 
rate, for example, can be computed from observed differences in orthologs across species in the context 
of their phylogenetic relationships (1). The age of a gene can be measured by tracing when the gene first 
appeared in the phylogenetic tree (2). These quantities allow researchers to chronicle the journey of 
individual genes across evolutionary history. 
But genes do not exist, and therefore do not evolve, in isolation. Mutations in a transcription 
factor may affect the expression of the genes it regulates, since changes in a protein’s amino acid 
sequence can cause it to lose compatibility with former binding partners, and gain compatibility with 
others. Accumulation of these alterations can lead to changes in fitness and, eventually, speciation. The 
evolution of individual genes is thus coupled with the evolution of the structure of the organism’s gene 
regulatory network (GRN), and network properties should be related to the evolutionary properties of 
its constituent nodes and edges. 
It has been proposed that GRNs grow and evolve incrementally via gene duplication followed by 
mutation and functional divergence (3-7), although changes may have occasionally arrived in bursts, as 
in whole-genome duplication (8). This time-dependent network formation suggests that GRNs are 
composed of a core of ancient, conserved genes with fundamental functions, and younger, peripheral 
genes with species- or cell type-specific function, which mutate frequently until the functions of the 
newly created pathways are optimized. These mutations can cause changes in GRNs by creating, 
removing, reassigning, or changing other properties of nodes and edges.  
Fraser et al. demonstrated that interacting pairs of proteins have similar evolutionary rates (9). 
This constraint is likely driven by the necessity of coevolution, since a change in one protein’s sequence 
may require a corresponding change in its partner’s sequence in order for the pair to remain 
compatible. Daub et al. showed that genes which are part of many biological pathways have lower 
evolutionary rates than genes which belong to few or no known pathways, further supporting the idea 
that related genes share similar evolutionary properties (10). It has also been shown that evolutionary 
rates are weakly, but significantly, negatively correlated with degree, closeness centrality, and 
betweenness centrality (network measures which quantify the importance of individual nodes in 
different ways) (11, 12), and that essential genes have high centrality and low evolutionary rates (13).  
It has been noted that the development of cancer cells within an individual is also a type of 
evolution, based on genetic variation and natural selection, but with many fundamental differences 
from the evolution of species, primarily the shorter time scale, the absence of sexual recombination, 
and the cells’ atavistic nature. In other words, cancer represents a partial return to a unicellular state, 
the only form of life until about 600 million years ago (2, 14-16). The first two differences limit the scope 
of cancer cell evolution, while the third suggests that modifying existing genes or sets of genes might be 
sufficient to revert to a unicellular-like state (2, 16).  
Armed with an increasingly comprehensive knowledge of the sets of genes most frequently 
mutated in various cancers (17), we can begin to study and understand their network properties. It was 
previously shown, for example, that genes which are commonly mutated in acute myeloid leukemia 
(AML) are located significantly closer to each other in their GRN than average (18). However, a general 
understanding of how network topology relates to both types of evolution remains elusive. 
Here, our goal is to establish quantitative relationships between the evolutionary history of 
genes and their topological properties in an AML-specific GRN, AML 2.3 (18), both in organismal 
evolution (using evolutionary rates and ages) and in cancer cell evolution (using sets of common driver 
mutations). The network properties of the genes changing in the two types of evolution are compared. 
We demonstrate that evolutionary rates and ages of genes are not uniformly distributed across the 
network, but are naturally organized in communities with well-defined evolutionary characteristics: old 
genes cluster with old genes, and young cluster with young. Likewise, “cold genes” (genes with low 
evolutionary rates) cluster with cold genes, and “hot genes” (genes with high evolutionary rates) cluster 
with hot genes. This segregation also exists for functional groups found to be enriched by the online 
gene ontology tool DAVID (19). In terms of network topology, we show that genes and functional groups 
which are old and cold tend to be central, and those which are young and hot tend to be peripheral. We 
demonstrate this with traditional single-node centrality measures, and find that PageRank (20), a finite-
range centrality measure, shows stronger biological significance than degree (a local measure) and 
betweenness centrality (a global measure). We also introduce two new network measures, the set 
efficiency (18) and the interset efficiency, which quantify the mean distance between nodes within a 
single set and between two sets, respectively. Finally, we use these relationships to examine the 
evolutionary and network properties of common cancer mutations, allowing us to identify a “cancer 
network core” which is significantly enriched for recurrent mutations. 
 
Results 
While computed differently, a gene’s evolutionary rate (ER) and its age are related. Young genes 
and functional groups with novel functions need time to fine-tune their properties in order to optimize 
the fitness of the host organism, so young genes tend to be hot. Likewise, old genes and functional 
groups with fundamental roles, such as protein translation, have had enough time to sufficiently 
optimize their functions, and so should change very slowly. As expected, the ERs and ages of the genes 
present in AML 2.3 are strongly correlated (𝑅 = 0.504, 𝑝 < 10−300).  
As previously demonstrated (9), interacting genes tend to have similar ERs and ages. The 
distributions of differences in ERs and ages between genes linked by an edge in AML 2.3 are significantly 
closer to zero than those of degree-preserving randomizations of the same network, with an 
approximate z-score of –96.8 for differences in ER and –72.0 for differences in age (see Figs. S1-S4). This 
tendency for connected genes to have similar ERs and ages hints that there may be large-scale 
segregation between clusters of old, cold nodes and young, hot nodes. Indeed, this is reflected in the 
natural community structure present in AML 2.3, as well as in biological functional groups present within 
these communities. Fig. 1A shows that the ER distribution of translational elongation genes is noticeably 
left-shifted relative to the ERs of all genes, indicating that it hosts slowly evolving. Transmembrane 
genes are much younger than average, as shown in Fig. 1B.  
Table 1 lists the ER and age properties for the ten largest communities in AML 2.3, and for the 
three most significantly enriched functional groups found within each community. Fig. 1C summarizes 
the main results of Table 1. The ERs and ages for many of these functional groups reflect their biological 
functions. Zinc finger proteins, for example, are involved in a large number of heterogeneous cellular 
processes (21), so their genes need to adapt more often than genes with very specific singular functions. 
They also have a particularly high rate of duplication and loss, so while the family itself is old (found in 
animals, plants (22), and fungi (23)), individual genes in this family are young (24). Genes involved in 
transcriptional regulation must also be flexible enough to tune the expression of target genes in 
response to environmental changes over time (25, 26). Conversely, the most fundamental functional 
groups have experienced few changes since early single-celled lifeforms. Functional groups such as 
mRNA metabolic process (27) and translational elongation (28) are old and stable, having long ago 
optimized their functions.  
The same analysis from Table 1 was conducted for a normal hematopoietic stem cell network 
(see Table S1B and Methods). This normal network is of lower quality than AML 2.3 because of the 
reduced number of samples; however, it serves as a qualitative control and further validates the results 
of our analysis. Table S2 compares Tables S1A and S1B between the AML and normal networks. Several 
of the same functional groups are enriched in both networks, and each has two enriched blood-specific 
functional groups (lymphocyte activation and hemoglobin complex for AML, and regulation of leukocyte 
activation and platelet alpha granule for normal). The lower quality of the normal network is evident in 
the p-values, as the findings for AML 2.3 are more significant.  
Traditional single-node centrality measures such as degree, betweenness centrality (29), and 
PageRank (20) show small but significant correlation with ERs and ages, with the oldest, coldest genes 
being the most central (see Tables S3A and S3B). Grouping genes by functional group leads to stronger 
relationships, the clearest of which is between the mean PageRank and mean  
age, shown in Fig. 2A (Pearson’s 𝑅 = −0.75, 𝑝 = 1 × 10−5; Spearman’s 𝜌 = −0.86, 𝑝 = 5 × 10−8). The 
corresponding values for degree and betweenness centrality are not significant. The plots of each 
centrality measure (degree, betweenness centrality, and PageRank, as well as the average of all three 
measures) versus ER and age are shown in Figs. S9-S16. These three centrality measures are related, but 
differ in their global reach. Degree is completely local, only dependent on the number of neighbors of a 
gene; betweenness centrality is global, requiring information from the entire network; but PageRank is 
between these extremes, influenced by all genes but with more weight granted to those genes which 
are near-by. The strong correlation between PageRank and ER thus may be explained by the presence of 
communities in the GRN, since community structure is strongly correlated with ER, as shown in Table 1. 
Because of the strong correlation between a gene’s history and that of its neighbors, genes are 
expected to evolve in groups rather than as individuals, which should be evident in the network. The set 
efficiency, the mean of the inverse distance between all pairs of nodes in a set (see Methods), is shown 
in Fig. 2B for genes ranked from coldest to hottest, and Fig. S6 for genes ranked from oldest to youngest. 
This indicates that the oldest, coldest genes tend to be close, separated by approximately four directed 
edges, significantly smaller than the network average of approximately six. The set efficiency 
monotonically declines as hotter, younger genes are included.  
Furthermore, the oldest functional groups efficiently exchange information with each other, and 
the youngest functional groups are distant from the oldest functional groups as well as from each other. 
Fig. 2C shows the interset efficiency, the mean of the inverse distance from all nodes in one set to all 
nodes in another (see Methods), between all pairs of functional groups from Table 1, where the 
functional groups are sorted from oldest to youngest. (Note that the diagonal terms of the interset 
efficiency matrix are the set efficiencies of the functional groups.) The abundance of connections 
between old functional groups and the scarcity between old-and-young and young-and-young functional 
groups suggests that during the course of human evolution, the primitive gene regulatory network 
began as a core of fundamental genes and pathways. As genes duplicated and mutated, novel functions 
arose and eventually, through selective duplications, deletions, mutations, and rewirings, novel 
regulatory pathways emerged, growing outward from these ancient genes. This would place the oldest 
genes near the middle of the network and the youngest genes toward the periphery.  
These observations can also be used to understand the action of disease-causing genes. 
Diseases can be caused by mutations in very young and hot functional groups, for example the 
hemoglobin complex in the top right corner of Fig. 1C, which is the functional group to which the 
inherited hemoglobinopathies belong.  
The evolutionary and network properties of cancer-causing mutations are, however, very 
different. As mentioned, cancer cells undergo a distinct type of evolution, that of the cells within an 
individual patient (14, 15). In Fig. 3A, we show that common AML-related mutations (30) are enriched in 
the top 5% of genes when ranked from highest to lowest average centrality (see Methods), identifying 
five out of 22 mutations with 𝑝 = 4 × 10−3. Ranking genes from lowest to highest evolutionary rate also 
performs well, capturing seven out of 22 mutations in the top 5% with 𝑝 = 7 × 10−5. But ranking genes 
by combining these measures in a composite score, computed from the mean of the average centrality 
and inverse evolutionary rate, identifies nine out of 22 mutations in the top 5% with 𝑝 = 5 × 10−7. 
Furthermore, this behavior is also observed when we consider a larger list of 198 genes relevant to 21 
different cancer types (17), as shown in Fig. 3B. The corresponding number of mutations are 36 using 
average centrality (𝑝 = 1 × 10−11), 30 using evolution rate (𝑝 = 5 × 10−8) and 40 using the composite 
score (𝑝 = 2 × 10−14).  
We are therefore capturing general properties of cancer causing genes. The composite score can 
be used to obtain an evolutionarily conserved and central core of the network, where the enrichment 
for cancer-causing mutations is strongly significant. Using the composite ranking we define the top 5% 
partition, which is the most enriched for cancer mutations, as the “cancer network core.” The properties 
we describe for the core do not depend on the precise definition of this partition; significant 
enrichments for cancer mutations are also present if we analyze the top 10% of the distribution. The 
interactions between the cancer network core and other sets of genes of equal size corresponding to 
the composite score ranges of Panels 3A and 3B are shown in Panel 3C. This is a representation of the 
AML Network in which the 20 partitions in Figs. 3A and 3B are represented by single nodes, and the 
width of each edge is proportional to the sum of all edge weights between the partitions. The edges 
were sorted by their weights and added to the network until each node had at least one edge. The 
central node in Fig. 3C, representing the cancer network core, is also the most connected node and its 
edges have the largest weights. The set efficiency and average interset efficiencies are also significantly 
higher in this cancer core compared to the other partitions, confirming the centrality of the core. 
The core genes are significantly enriched in some functional groups, being over-represented in 
colder, older functional groups and under-represented in younger, hotter functional groups, especially 
membrane proteins (Fig. 3D). This may be explained by the fact that membrane proteins have 
underlying differences in their ERs that makes using the composite score (weighted to find colder genes) 
ineffective. It is therefore clear that the definition of the cancer network core could be eventually 
systematically improved using functional information. This may be possible in the future when more 
data is made available, allowing us to construct a larger set of comparable networks for different cancer 
types. 
 
Discussion 
We have shown that slowly evolving, old genes tend to interact with each other, and frequently 
evolving, young genes tend to interact with each other. While these findings are mainly derived from an 
analysis of the AML network, they were broadly confirmed in a normal hematopoietic network and are 
consistent with previous reports (13). This supports the hypothesis that GRNs evolved and grew via gene 
duplication, in which a core of ancient genes with fundamental functions (such as cell cycle regulation 
and management of RNA) spawned new sets of genes. As these new genes’ functions became more 
refined and specialized, new pathways emerged. Many rounds of this process would place the ancient 
genes in the center of the new network, and the newer elements would tend to be on the network’s 
periphery.  
Our data also show that genes which are conserved in organismal evolution are more likely to 
be frequently mutated in cancer cells that evolve within a single organism, which points to the high 
degree of adaptation to multicellular life of the core of the cellular network that cancer is subverting. 
The result is consistent with the view that cancer is a reversion to primitive unicellular state by 
modifications of older groups of genes. 
No gene is an island. A real understanding of the evolution of a genome only comes from 
studying its constituent genes in the context of the underlying complex network of interactions rather 
than as independent entities. This suggests that cancer should be considered a disease of the cancer 
network core, rather than of individual genes, and that therapies should aim to preferentially affect the 
activity of the core, rather than individual targets. This is a testable hypothesis because suitable drugs 
and methods to design drug combinations are increasingly available (31). 
Although this analysis focused on an AML-specific network, several results, including the 
enrichment of genes recurrently mutated in 21 cancer types, show that our findings are of general 
relevance. As network reconstruction methods continue to improve and more high quality networks 
become available, we expect to find more evidence of how evolution shapes the topology of gene 
regulatory networks. 
 
Conclusions 
We demonstrated that the evolutionary history of human genes had a significant impact on the 
development of GRNs. We provided strong evidence for the coevolution of interacting genes, and 
showed that this constraint produces natural community structures with well-defined evolutionary 
characteristics. These characteristics are also present in the functional groups enriched within these 
communities. The enriched functional groups exchange information with each other with differing 
efficiency: the oldest, coldest functional groups are close to each other, whereas the youngest, hottest 
functional groups are more dispersed.  
We also introduced a composite measure, which integrates single-gene evolutionary 
information with network centrality. This measure was used to identify a cancer network core which 
shows significant enrichment of common cancer mutations in the oldest, coldest, most central genes, 
i.e. genes with precisely the opposite properties of those which mutate most frequently and drive the 
evolution of multicellular organisms. Integrating evolutionary and network centrality information could 
therefore help in determining whether newly discovered mutations contribute to carcinogenesis (so 
called driver mutations) or are simply passengers. When drugs directly affecting the mutations are not 
available, we could prioritize interventions acting on the genes in the cancer core. 
 
Methods 
Evolutionary rate and age. To compute the evolutionary rate (ER) of a gene, we first calculated the 
absolute ER for each amino acid position of the protein it encodes using the method from Kumar et al. 
(1). Given the multiple alignment at an amino acid position in 46 species (32), its ER equals the number 
of different residues divided by the total evolutionary time span, based on a known phylogenetic tree 
(1). The ER of a gene is the average of ERs over all amino acid positions, in units of the number of 
substitutions per amino acid site per billion years. The ER value ranges from ~0.011 (most conserved) for 
LSM23 to ~6.928 (least conserved) for CDRT15. Ages, taken from Chen et al. (2), were estimated from 
comparing the human genome to the genomes of 13 major clades with origins at different points along 
the human clade, indexed 0 (oldest) through 12 (youngest). A gene’s age was determined by searching 
for the earliest time at which an orthologous gene appears in an organism which branched from the 
human clade. 
Network and DAVID functional groups. The gene regulatory network used in this analysis, “AML 2.3”, is 
a partially directed, weighted acute myeloid leukemia (AML) GRN (18). This network was chosen 
primarily for its quality. It was constructed from more than 1,800 patients across 12 studies from both 
microarray and RNA-seq gene expression measurements in AML cells, and it is a high confidence 
network. Additionally, a network constructed from data from a single cell type (in this case, myeloblast 
cells) focuses on the most active, relevant interactions in that cell type. 
A weighted, directed, modularity-based community-finding algorithm was used to divide the 
10,062 genes into 133 communities (33). A spy plot of the adjacency matrix after community sorting is 
shown in Fig. S5. The ten largest communities were selected for further analysis (see Table 1). The 
individual communities were then provided to the DAVID functional annotation tool to identify enriched 
functional groups in the communities (19). The top three distinct enriched functional groups with 
Benjamini values less than 10−4 in each community are also included in Table 1. 
Communities and functional groups in Table 1 labeled “cold” and “hot” have significantly lower 
and higher evolutionary rates (ERs) than the network average, respectively. Likewise, groups of genes 
labeled “old” and “young” are significantly older and younger than the network’s average age, 
respectively. A one-tailed significance level of 𝑝 < 10−3 in the difference from the mean was chosen for 
both ER and age. The Kolmogorov-Smirnov (KS) statistic and p-value were also computed for each 
community and functional group to quantify the difference between the distribution of all genes and the 
distribution of each set of genes, which is shown Table S1A. Some example functional group 
distributions are shown in Fig. 1A and 1B, and all distributions are shown in Figs. S7 and S8 for ERs and 
ages, respectively. A summary of the ERs and ages of the enriched functional groups in Table 1 is shown 
in Fig. 1C. The same analysis was conducted for normal hematopoietic stem cell network built from five 
datasets (GSE48846, 2666, 33223, 24759, and 30376) using the same method as for AML 2.3, with the 
data reported in Table S1B.  
ERs and ages between interacting genes. To determine the significance of the correlation between ERs 
and gene-gene interactions, the difference in evolutionary rates between all gene pairs connected by an 
edge was computed for AML 2.3 as well as for degree-preserving randomizations of AML 2.3. Fig. S1 
shows the distribution of (𝐸𝑅𝑗 − 𝐸𝑅𝑖) for all gene pairs (𝑖, 𝑗) which are connected by an edge 𝑗 → 𝑖 in 
AML 2.3 (green distribution), as well as for all pairs of genes in one degree-preserving randomization of 
the same network (purple distribution). Note that the distributions are asymmetric because AML 2.3 is a 
directed network. The real distribution of ER differences has a smaller standard deviation than for the 
randomized network, meaning that difference in evolutionary rates between interacting genes is small 
on average, in agreement with Fraser et al. (9). To quantify the significance of this difference, AML 2.3 
was randomized 20,000 times and the standard deviation of each set of ER differences was recorded, as 
shown in Fig. S2. This gave a z-score of –96.8 for the ER differences in the real network. Since none of 
the sampled randomized networks had an ER difference width less than that of the real network, an 
upper limit of 5.0 × 10−5 was placed on the p-value. The same procedure was used to find the 
significance in the age difference between connected genes, which resulted in a z-score of –72.0 and an 
upper limit of 5.0 × 10−5 for the p-value (see Figs. S3 and S4). 
Centrality measures. The average centrality for a given gene is defined as the mean of its degree, 
betweenness centrality, and PageRank. Each of these quantities was scaled such that the minimum and 
maximum values were 0 and 1, respectively. The inverted ER was similarly scaled to the range [0,1]. The 
composite score is the mean of the average centrality and inverted ER. Significance values for the 
number of mutations in the top 5% for all three rankings shown in Figs. 3A and 3B were computed using 
a hypergeometric distribution. 
Global, set, and interset efficiency. The global efficiency (34) of a network is defined as 
𝐸𝑔𝑙𝑜𝑏𝑎𝑙 =
1
𝑛(𝑛 − 1)
∑
1
𝑑𝑖𝑗
𝑖≠𝑗
 
where 𝑛 is the number of nodes in the network, 𝑑𝑖𝑗  is the unweighted distance from node 𝑗 to node 𝑖, 
and 0 ≤ 𝐸𝑔𝑙𝑜𝑏𝑎𝑙 ≤ 1 for unweighted networks. We define the set efficiency (SE) of a set of nodes 𝑀 as 
𝐸𝑀 =
1
|𝑀|(|𝑀| − 1)
∑
1
𝑑𝑖𝑗𝑖,𝑗∈𝑀,
𝑖≠𝑗
 
where |𝑀| is the number of nodes in 𝑀, and 0 ≤ 𝐸𝑀 ≤ 1 for unweighted networks. 𝐸𝑀 > 𝐸𝑔𝑙𝑜𝑏𝑎𝑙 
implies that nodes in 𝑀 are closer to each other than average in the network, and 𝐸𝑀 < 𝐸𝑔𝑙𝑜𝑏𝑎𝑙 implies 
that the nodes are more dispersed than average. Note that 𝑑𝑖𝑗  is calculated using the full network, so 
shortest paths from 𝑗 to 𝑖 may pass through nodes which are not in 𝑀. The SE was thus used to examine 
the topological distribution of ERs and ages in AML 2.3. The ERs were sorted from coldest to hottest, and 
the SE of the first 500 genes was computed, increasing the window size in steps of 10 genes from the 
beginning to the end of the ER list. The resulting curve is shown in blue in Fig. 2B. Also pictured is the 
mean of the controls (solid green line) plus/minus one standard deviation (dashed green lines), which 
were obtained by randomizing the order of the genes 100 times and computing the cumulative SE in the 
same manner. See Fig. S6 for the same plot using age rather than ER. 
We define the interset efficiency (IE) from node set 𝐽 to node set 𝐼 as 
𝐸𝐼𝐽 =
1
|𝐼||𝐽| − |𝐼 ∩ 𝐽|
∑
1
𝑑𝑖𝑗𝑖∈𝐼,𝑗∈𝐽,
𝑖≠𝑗
 
where |𝐼 ∩ 𝐽| is the number of nodes shared by sets 𝐼 and 𝐽, and 0 ≤ 𝐸𝐼𝐽 ≤ 1 for unweighted networks. 
As with the set efficiency, shortest paths may pass through nodes which are neither in 𝐼 nor 𝐽. Note that 
this formulation is defined when sets 𝐼 and 𝐽 have a non-empty intersection, and that the diagonal terms 
of the interset efficiency reduce to the set efficiency, i.e. 𝐸𝐼𝐼 = 𝐸𝐼. A large 𝐸𝐼𝐽 implies that the average 
distance from nodes in 𝐽 to nodes in 𝐼 is small, and a small 𝐸𝐼𝐽 implies large distances. 𝐸𝐼𝐽 is asymmetric 
for directed networks. This measure was used in Fig. 3 to quantify the proximity of the functional groups 
from Table 1. 
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 Figure 1. [A] Distribution of evolutionary rates (ERs), measured in units of the number of nonsynonymous substitutions per 
amino acid site per billion years, for all genes (purple) and for genes in the translational elongation functional group (green). 
This functional group has a very low ER compared to the background distribution. [B] Distribution of ages for all genes (purple) 
and genes in the transmembrane functional group (purple), where age=0 is the oldest and age=12 is the youngest. 
Transmembrane genes are much younger than average. [C] Summary of average ER and age for communities and functional 
groups in Table 1. The x-values are computed from 𝐸𝑅𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 = 𝐸𝑅𝑓𝑢𝑛𝑐.  𝑔𝑟𝑜𝑢𝑝 𝑚𝑒𝑎𝑛 − 𝐸𝑅𝑛𝑒𝑡𝑤𝑜𝑟𝑘 𝑚𝑒𝑎𝑛, and likewise for 
relative age on the y-axis. The functional groups from [A] and [B] have bold labels in [C]. Each marker type corresponds to one 
of communities 0 through 9. As expected, old functional groups tend to have a low average ER (i.e. are “cold”), and young 
functional groups tend to evolve frequently (i.e. are “hot”). Unabbreviated functional group names are listed in Table 1.  
  
 Figure 2. [A] Mean PageRank versus mean age each functional group from Table 1, where age=0 is the oldest and age=12 is the 
youngest. Old functional groups have high PageRank, and vice versa. Unabbreviated functional group names are listed in Table 
1. [B] The cumulative set efficiency (SE) of all genes below a given evolutionary rate (ER) rank (lowest to highest ER, i.e. 
“coldest” to “hottest”). The SE of the 500 coldest genes is significantly higher than the control, and including hotter genes 
monotonically decreases the SE. This indicates that the coldest genes exchange information efficiently, while the hottest genes 
are more dispersed and thus communicate less efficiently than average. [C] Interset efficiency from functional group in column 
𝑗 to functional group in row 𝑖. The list of functional groups was sorted by average age from oldest (transcriptional elongation) to 
youngest (hemoglobin complex). There is a highly efficient exchange of information between old functional groups, as indicated 
by the high interset efficiency values in the lower left corner. Recently developed functional groups, particularly the blood cell-
specific functional groups of lymphocyte activation and hemoglobin complex, are remote from most other functional groups. 
Note that the above matrix is asymmetric because the network is directed, and that the colors are log-scaled. 
 Figure 3. [A] Genes ranked by average centrality (green, highest centrality on the left), evolutionary rate (blue, lowest rate on 
the left) and a composite score including both quantities (red). The ranked values are divided into partitions, each including 5% 
of the genes. The height of each bar indicates the number of the 22 most common acute myeloid leukemia (AML) mutations 
present in each partition. [B] Genes ranked in the same way as in Fig. 3A, but for the 198 most common mutations across 21 
different types of cancer. [C] AML network composed by nodes representing each of the 20 composite score partitions from 
panels A and B. Edges show the strength of connections between the genes within each partition. The numbers within the 
nodes show the cancer mutations, as in panel B. We define the central node, corresponding to the partition with the highest 
composite score, as the “cancer network core.” This is the node with the highest number of mutations and connections to the 
other nodes. [D] The fraction of genes from the cancer network core present in the 25 functional groups from Table 1. The 
horizontal black line is the control, representing the expected fraction for a random set of genes of equal size. Functional 
groups with 𝑝 < 10−4 (computed from a hypergeometric distribution) are labelled with a star.  
  
 
 
Table 1. Community and functional group structures present in our acute myeloid leukemia network, AML 2.3, with 
corresponding evolutionary rate (ER) and age properties. Gene ERs take real values from 0 (most conserved) to approximately 
6.9 (most variable), and ages take integer values from 0 (oldest) to 12 (youngest). The table is organized as follows: "Comm. 
Index" is the index of the ten largest communities; "Num. genes" is the number of genes in the community; "Comm. ER" 
indicates whether the community is significantly hotter (i.e. has a higher evolutionary rate) or colder (i.e. has a lower 
evolutionary rate) than the mean of 300 equally-sized sets of randomly selected genes, with a significance threshold of 
𝑝 = 10−3; "Diff. in mean" is the difference between the mean ER of the community and the mean ER of the 300 randomly 
selected sets; "p-value" is the significance of the difference; "Comm. age", "Diff. in mean", and "p-value" are the same as 
previously stated, but for age rather than ER; "DAVID functional group" is the name of the functional groups that DAVID 
identified as enriched in each community; "Num. genes" is the number of genes in the functional group; "DAVID Benjamini" is 
the significance of the enrichment of the functional group, as reported by DAVID; and the remaining functional group columns 
are computed in the same manner as the community columns. 
Zinc finger 275 2.6E-39 hot 0.32 6.0E-19 young 0.75 4.4E-05
Transcription regulation 298 1.9E-16 hot 0.28 4.8E-14 young 1.17 9.3E-11
Transcription 304 4.8E-24 average -0.05 4.6E-02 young 0.69 5.6E-05
Intracellular organelle lumen 239 9.7E-19 average -0.07 7.1E-02 old -1.18 1.7E-08
Protein localization 145 2.9E-10 cold -0.27 7.3E-05 old -1.50 5.2E-08
Nuclear lumen 332 8.4E-107 cold -0.21 2.6E-07 old -1.94 1.6E-28
Cell cycle phase 169 3.6E-98 average 0.06 1.0E-01 old -1.67 5.4E-07
Response to DNA damage stimulus 135 3.5E-58 average 0.03 3.1E-01 old -1.97 3.2E-07
Cell-cell signaling 146 3.6E-39 cold -0.16 7.0E-04 young 1.12 1.3E-05
Plasma membrane part 359 1.1E-67 cold -0.11 2.5E-04 young 0.82 4.1E-06
mRNA metabolic process 124 9.5E-66 cold -0.46 2.7E-25 old -1.84 2.7E-06
Nuclear lumen 212 9.3E-60 cold -0.34 5.3E-24 old -1.45 1.2E-09
mRNA transport 27 1.2E-11 average -0.36 5.8E-03 average -2.17 7.2E-03
Establishment of protein 105 1.1E-19 cold -0.33 5.2E-09 old -2.03 1.6E-12
Actin filament-based process 51 1.9E-16 cold -0.41 9.0E-06 old -1.96 9.0E-06
Regulation of programmed cell 79 2.6E-07 average -0.03 4.2E-01 average -0.63 3.0E-02
Lymphocyte activation 40 1.2E-11 hot 0.68 1.2E-10 young 3.27 6.2E-11
Hemoglobin complex 13 1.3E-12 average 0.54 5.1E-03 young 4.43 1.1E-04
Transmembrane 252 1.8E-05 hot 0.51 2.0E-34 young 2.55 4.5E-28
Mitochondrial envelope 103 1.0E-68 average -0.14 2.0E-02 old -1.98 4.5E-10
Respiratory chain 44 4.9E-47 average 0.03 3.4E-01 old -1.57 9.3E-05
Ribosomal protein 62 2.4E-53 average 0.18 2.3E-02 old -1.73 3.2E-05
8 296 hot 0.16 1.5E-05 young 1.49 4.8E-14 Homeobox 27 2.2E-12 average -0.22 7.3E-02 young 3.01 3.7E-07
Translational elongation 77 1.7E-114 cold -0.60 6.0E-18 old -3.04 1.7E-13
rRNA processing 27 1.1E-22 average -0.24 3.2E-02 old -2.93 1.7E-05
-1.54 8.3E-22
9 270 cold -0.28 5.7E-14 old -1.96 2.9E-20
7 417 average -0.08 1.2E-02 old
-0.91 5.1E-10
6 748 hot 0.18 3.5E-22 young 1.34 2.8E-29
5 780 cold -0.11 1.1E-05 old
4 867 cold -0.27 3.7E-55
3 1055 average 0.01 2.4E-01 1.41 5.4E-53
old -0.94 1.7E-16
young
6.8E-07
2 1208 cold -0.10 2.6E-10 old -1.30 1.2E-58
old -0.391 1579 average -0.03 2.3E-02
0 1760 hot 0.24 2.5E-81
Diff. in 
mean
p-value
young 1.01 6.7E-28
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